The study and its comparison
Twenty adults with major depressive disorder received 250 milligrams daily for eight weeks. Researchers assessed depression, anxiety, sleep and cognitive performance before and during treatment. [1]
Several scores improved, including depression ratings and selected cognitive measures. Some sleep findings concerned participants whose depression had not remitted at baseline. [1]
What the finding establishes
Without a placebo group or blinding, improvement could reflect expectations, time, ongoing care or other influences. The study supports a controlled test rather than establishing antidepressant efficacy or long-term safety. Funding and conflicts were not established from the abstract. The regimen should not be interpreted as a reason to change prescribed treatment independently. [1]
A hypothetical distinction
Imagine symptoms improve after adding a supplement while other treatment continues. Timing alone does not show which factor produced the change.
| Detail | Interpretation |
|---|---|
| Measured outcome | Keep the endpoint specific |
| Study preparation | Not every retail product |
| Remaining uncertainty | Not resolved by a mechanism |
Sources for this article
- Effects of chronic l-theanine administration in patients with major depressive disorder: an open-label study - PubMed
Source consulted: 2026-09-19. This is a reference resource, not a claim that we conducted the studies or tested a product.